Autologous hematopoietic stem cell transplantation (AHSCT) induces suppression of clinical-radiological inflammatory activity even in aggressive multiple sclerosis (aMS). However potential neurotoxicity of the procedure, with possible impact on physical and cognitive disability, has recently been suggested. We present a retrospective analysis evaluating the impact of intermediate-intensity AHSCT on cognitive performances in aMS patients treated at the University-Hospital of Careggi in Florence in the period 2016-2020.
Neuropsychological assessment in aggressive multiple sclerosis treated with stem cell transplantation / Mariottini, A., Farina, A., Innocenti, C., Romoli, M., Zilio, I., Azzolini, F., Repice, A., Saccardi, R., Carlucci, G., Massacesi, L.. - In: EUROPEAN JOURNAL OF NEUROLOGY. - ISSN 1351-5101. - ELETTRONICO. - 28:(2021), pp. 362-362.
Neuropsychological assessment in aggressive multiple sclerosis treated with stem cell transplantation
Mariottini, A
;Farina, A;Innocenti, C;Romoli, M;Zilio, I;Azzolini, F;Repice, A;Saccardi, R;Carlucci, G;Massacesi, L
2021
Abstract
Autologous hematopoietic stem cell transplantation (AHSCT) induces suppression of clinical-radiological inflammatory activity even in aggressive multiple sclerosis (aMS). However potential neurotoxicity of the procedure, with possible impact on physical and cognitive disability, has recently been suggested. We present a retrospective analysis evaluating the impact of intermediate-intensity AHSCT on cognitive performances in aMS patients treated at the University-Hospital of Careggi in Florence in the period 2016-2020.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
